Part 2: Drug Interactions Involving Cannabis Products in Persons Aged 18 and Over: A Summary of Published Case Reports and Analysis of the FDA Adverse Event Reporting System is a research paper published in Pharmacology Research & Perspectives (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. National Library of Medicine
Grant: T15 NLM007059
National Institutes of Health
Grant: 1R01HD081299-01A1
PBPK prediction of ontogeny mediated alteration in hepatic drug elimination
National Institutes of Health
Grant: 5R16GM146679-04
Quantifying effects of comorbidities and genetics on cannabinoid exposure in the elderly
National Institutes of Health
Grant: 5U01DK130010-03
The Pittsburgh Scientific and Data Research Center for the COPE-AKI Consortium (Pitt-SDRC)
National Institutes of Health
Grant: 1R01DK121730-01A1
(MEnD-AKI) Multicenter Implementation of an Electronic Decision Support System for Drug-associated AKI
National Institutes of Health
Grant: 5T15LM007059-20
Pittsburgh Biomedical Informatics Training Program
National Institutes of Health
Grant: 2U54AT008909-06
Natural Product-Drug Interaction Research: The Roadmap to Best Practices
NLM NIH HHS
Grant: T15 LM007059
NCCIH NIH HHS
Grant: U54 AT008909
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals